Search Results
Dec 09, 2025, 06:45 ET Export-Import Bank of the United States and Export Finance Australia Provide Conditional and Non-Binding Support for Potential Financing of up to US$600 Million to Advance Tronox's Rare Earth Strategy
build out a rare earth elements supply chain. Tronox recently completed a pre-feasibility study and is now progressing to a definitive feasibility study for a proposed cracking and leaching facility in Western Australia to produce a mixed rare earth carbonate including both light and heavy rare earths. Tronox
More news about: Tronox Holdings plc
Dec 09, 2025, 06:00 ET Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)
recent commitments to clearer, more efficient pathways for rare disease drug development and to ensuring science and efficacy-driven decision-making are encouraging," said Dave Penake, chief executive officer of Saol Therapeutics. "For an ultra-rare condition like PDCD, the challenge is navigating a regulatory
More news about: Saol Therapeutics
Dec 09, 2025, 05:03 ET Setting the Standard: Renegade Talent at the Heart of Volleyball's Rise
MGMT.The sport's expansion is unlike any other women's sport in history. It wasn't long ago that large-scale national attention for women's volleyball was rare. Today, sellout arenas, primetime broadcasts, and mass media praise are not only possible but expected. The Penn State vs. Nebraska semifinal match in
More news about: CelebExperts
Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
The research findings validated golidocitinib's long-lasting efficacy and tolerability in the U.S. patient population.Rare subtypes of PTCLGolidocitinib monotherapy demonstrated compelling clinical activity with a favorable safety profile in heavily
More news about: Dizal Pharmaceutical
Dec 09, 2025, 03:30 ET Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory Board with a focus on its lead indication Alport Syndrome
which includes genomic testing for rare kidney diseases such as Alport Syndrome.Professor Bertrand Knebelmann – Professor of Nephrology at Université Paris Cité, and Necker Hospital, and co-director of both the Reference Center for Rare Diseases for Hereditary Renal Diseases
More news about: Fibrocor Therapeutics
Dec 09, 2025, 02:53 ET Sweden Recommends: A Dose of Northern Lights Therapy
rare solar maximum is underway, making aurora displays brighter, more frequent and easier to catch. Sweden offers front-row access to one of nature's
More news about: Visit Sweden AB
Dec 09, 2025, 02:53 ET Sweden Recommends: A Dose of Northern Lights Therapy
rare solar maximum is underway, making aurora displays brighter, more frequent and easier to catch. Sweden offers front-row access to one of nature's
More news about: Visit Sweden AB
Dec 09, 2025, 02:47 ET Innoviti Appoints Sandeep Mina As Chief Business Officer - Retail
company is now bolstering its leadership for a sustained period of profitable hyper-growth leading to an exit in near future."Sandeep brings a rare combination of strategic and execution muscle at a time when Innoviti's core business has turned cash flow positive and the new businesses of genie
More news about: Innoviti Technologies Pvt. Ltd.
Dec 09, 2025, 01:54 ET GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
leading diagnostics company that aims to connect the care and cure to the world by offering genetic diagnosis services for Oncology, Pre&Neonatal, Rare Diseases, and Health Check-ups and suggesting personalized treatment for longer and healthier lives. Established in 2013 as a GC company, GC Genome
More news about: GC Genome
Dec 08, 2025, 18:19 ET The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered "virtual hearts"
drugs to later stages, enabling safer, more precise decisions about which therapies should move forward.Capturing rare but dangerous reactionsFor heart drugs, rare toxicities are a leading reason for failure. Even if only one in a thousand patients experiences a severe reaction during
More news about: The Jackson Laboratory
Dec 08, 2025, 16:43 ET Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
-- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to initiate the company's
More news about: Cereno Scientific
Dec 08, 2025, 16:40 ET Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
-- Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to initiate the company's
More news about: Cereno Scientific
Dec 08, 2025, 16:15 ET AutoNation and Florida Panthers Deliver Hope to Pediatric Cancer Patients at Joe DiMaggio Children's Hospital
TaKobe has been bravely fighting a rare and aggressive tumor and has undergone surgery, chemotherapy and radiation treatments. At the recent Florida Panthers game against the Columbus Blue
More news about: AutoNation, Inc.
Dec 08, 2025, 13:17 ET STEPHEN ELLSWORTH, CO-FOUNDER OF POPPI, JOINS DROPOUT COMPANIES AS OPERATING PARTNER
product innovation, and strategic scaling to support Dropout's mission of reimagining childhood classics for today's families. "Stephen brings a rare combination of operational rigor and culturally relevant brand building," said Connor Blakley, Founder of DropOut Companies. "He and Allison established
More news about: DropOut Companies
Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
Myelofibrosis (MF)MF is a rare type of blood cancer that is characterized by the buildup of fibrous tissue in the bone marrow, which can affect the production of blood cells. This buildup is caused by dysregulation in the JAK signaling pathway. MF is a serious and rare disease with 0.7 new cases per
More news about: Sumitomo Pharma America
Dec 08, 2025, 11:13 ET Children's Hospital of Philadelphia Researchers Identify Concerning Increase in Newborns Not Receiving Preventative Vitamin K Shots
Newborns receive a vitamin K intramuscular shot at birth to prevent a rare but serious condition called vitamin K deficiency bleeding (VKDB). This bleeding disorder can occur because newborns naturally have low levels of vitamin
More news about: Children's Hospital of Philadelphia
Dec 08, 2025, 11:13 ET Moutai Cultural Exhibition Ignites U.S. Audience with Immersive Journey Through a Century of Cultural Heritage
"San Francisco: In Search of Our Shared Memory - 1915 Through the Eyes of a Chinese Brand," the Moutai cultural exhibition blended historical photos, rare archives, and contemporary installations into a multisensory narrative. The experience transported visitors from the "Jinshan" projection, which revived
More news about: Kweichow Moutai
Dec 08, 2025, 11:11 ET Public Affairs and Patient Advocacy Leader Kim Isenberg Joins National Organization for Rare Disorders Board of Directors
Organization for Rare Disorders Founded in 1983, the National Organization for Rare Disorders (NORD®) is a leading independent, nonpartisan, nonprofit and patient advocacy organization dedicated to improving the health and lives of over 30 million Americans living with rare diseases. In partnership
More news about: National Organization for Rare Disorders (NORD®)
Dec 08, 2025, 10:01 ET AI Voice Generator Market worth $20.71 billion by 2031 | MarketsandMarkets™
Generator Market is advancing quickly as vendors adopt multilingual speech pipelines powered by self-supervised models that support 40–100+ languages and rare dialects, enabling large-scale localization for global brands. At the same time, gaming studios are increasingly using AI voices for NPCs and dynamic
More news about: MarketsandMarkets
Dec 08, 2025, 10:00 ET Lyons & Simmons Promotes Michael Fechner to Partner
for his thorough preparation and practical, client-focused approach to personal injury and wrongful death trial work."Michael demonstrates the rare combination of skill, determination, and enthusiasm for our practice but also holds an authentic desire to improve his clients' lives and the safety
More news about: Lyons & Simmons, LLP
Dec 08, 2025, 09:00 ET The Galien Foundation Honors 2025 Prix Galien Bridges Awards Recipients
intelligence that are transforming how we prevent, detect, monitor, and treat disease.Best Product for Rare/Orphan DiseasesRecognizes exceptional products that address rare and orphan diseases—conditions where scientific complexity and small patient populations create unique development
More news about: The Galien Foundation
Dec 08, 2025, 09:00 ET Imre taps Ogilvy's Nadine Lafond as CEO to lead bold, new phase of agency evolution
immunology, and rare disease. She spent more than a decade at Ogilvy Health North America, most recently as Chief Client Officer for North America and President of Ogilvy Health Canada, where she led major U.S. businesses, drove growth across cardiometabolic, neurology, oncology, and rare disease, and helped
More news about: Imre
Dec 08, 2025, 09:00 ET MIKEWORLDWIDE APPOINTS ABRAHAM ESPINOSA AS EXECUTIVE VICE PRESIDENT OF STRATEGY
and Verizon. As one of America's few bicultural strategists, he operates across three dimensions: Global, General Market and Multicultural, bringing a rare cultural and strategic fluency to brand challenges. A PRWeek 40 Under 40 honoree, he previously held strategic leadership roles at agencies including
More news about: MikeWorldWide
Dec 08, 2025, 08:44 ET Gothic Beauty Magazine Reunites Original Contributors for 25th Anniversary Retrospective Interview Series and Calendar
scenes, and collaborations that have endured for decades.A companion Kickstarter campaign offers a limited-edition retrospective calendar featuring rare archival imagery. Kickstarter has designated this a #ProjectWeLove which Kickstarter describes as their "way of highlighting brilliant examples of creativity."
More news about: Gothic Beauty
Dec 08, 2025, 08:30 ET Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy
Australian-based explorer focused on critical minerals. The company is actively advancing its U.S. Asset, the Mojave Project, in California, targeting rare earth elements (REE) and antimony (The Desert Antimony Mine). The company also has a strategic collaboration with Rice University to develop DeepSolv™
More news about: Locksley Resources